Cargando…

Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) continues to present a challenge in the clinic, as there is still no approved targeted therapy. TNBC is the worst sub-type of breast cancer in terms of prognosis and exhibits a deficiency in estrogen, progesterone, and human epidermal growth factor 2 (HER2) recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sneider, Alexandra, Jadia, Rahul, Piel, Brandon, VanDyke, Derek, Tsiros, Christopher, Rai, Prakash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292187/ https://www.ncbi.nlm.nih.gov/pubmed/28174679 http://dx.doi.org/10.7150/oncm.17406

Ejemplares similares

Remotely Triggered Nano-Theranostics For Cancer Applications
por: Sneider, Alexandra, et al.
Publicado: (2017)

Co-Administered Polymeric Nano-Antidotes for Improved Photo-Triggered Response in Glioblastoma
por: Kydd, Janel, et al.
Publicado: (2018)

Nanoparticles for Effective Combination Therapy of Cancer
por: Jadia, Rahul, et al.
Publicado: (2016)

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer
por: Si, Yingnan, et al.
Publicado: (2021)

Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
por: Kydd, Janel, et al.
Publicado: (2017)

Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019)

Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

De la línea al diseño : comunicación, diseño, grafismo
por: VanDyke, Scott, 1954-

Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer
por: Jin, Xin, et al.
Publicado: (2020)

Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
por: Ding, Yinan, et al.
Publicado: (2021)

Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy
por: Gad, Aniket, et al.
Publicado: (2016)

Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer
por: Zeng, Fan, et al.
Publicado: (2015)

MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice
por: Amrahli, Maral, et al.
Publicado: (2021)

Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes
por: Xia, Jiaxuan, et al.
Publicado: (2022)

GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
por: Velpurisiva, Praveena, et al.
Publicado: (2018)

Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells
por: Liu, Qiuyu, et al.
Publicado: (2022)

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer
por: Noureddine, Lara Malik, et al.
Publicado: (2023)

Cancer nanomedicine: a review of recent success in drug delivery
por: Tran, Stephanie, et al.
Publicado: (2017)

pH-Triggered Echogenicity and Contents Release from Liposomes
por: Nahire, Rahul, et al.
Publicado: (2014)

Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
por: De Vita, Alessandro, et al.
Publicado: (2021)

Ultrasound-triggered herceptin liposomes for breast cancer therapy
por: Elamir, Amal, et al.
Publicado: (2021)

Toxin-Triggered Liposomes for the Controlled Release of Antibiotics to Treat Infections Associated with Gram-Negative Bacteria
por: Li, Ziang, et al.
Publicado: (2023)

Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model
por: Price, Lauren S.L., et al.
Publicado: (2021)

Co-Delivery of 5-Fluorouracil and Paclitaxel in Mitochondria-Targeted KLA-Modified Liposomes to Improve Triple-Negative Breast Cancer Treatment
por: Chen, Tianyu, et al.
Publicado: (2022)

Blastomyces dermatitidis Yeast Lysate Antigen Combinations: Antibody Detection in Dogs with Blastomycosis
por: Boyd, Alex R., et al.
Publicado: (2013)

ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
por: Guo, Peng, et al.
Publicado: (2016)

(89)Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy
por: Yang, Rui, et al.
Publicado: (2020)

How message appeals and prior product use influence information processing, risk perceptions, trust, attitudes, and genetic test purchase intentions
por: VanDyke, Matthew S., et al.
Publicado: (2023)

Neighborhood Social Determinants of Triple Negative Breast Cancer
por: Hossain, Fokhrul, et al.
Publicado: (2019)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Surface Engineering of Liposomes for Stealth Behavior
por: Nag, Okhil K., et al.
Publicado: (2013)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
por: Xun, Xueqiong, et al.
Publicado: (2022)

Death Following Ingestion of an Edible Marijuana Product — Colorado, March 2014
por: Hancock-Allen, Jessica B., et al.
Publicado: (2015)

Theranostic Attributes of Acoustic Cluster Therapy and Its Use for Enhancing the Effectiveness of Liposomal Doxorubicin Treatment of Human Triple Negative Breast Cancer in Mice
por: Bush, Nigel, et al.
Publicado: (2020)

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
por: G., Vigneshwaran, et al.
Publicado: (2022)

Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer
por: Umekita, Yoshihisa, et al.
Publicado: (2011)

TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
por: Iriondo, Oihana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6mktclcl4amtc2409p9t5u36av